Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-03

Clinical Trial Update: Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 trial update for Curosurf in adult acute respiratory distress syndrome due to COVID-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curosurf (poractant alfa)

Snippet

Sponsor: Dr Christophe LENCLUD | Conditions: COVID-19, ARDS, Human | Phase 2 | Status: UNKNOWN